| DAIICHI SANKYO CO. LTD |
| Japan |
| Gesundheit |
| JP3475350009 / A0F57T |
| D4S (Frankfurt) |
| FRA:D4S, ETR:D4S, D4S:GR |
| Nikkei225 |
| https://www.daiichisankyo.. |
|
Daiichi Sankyo Co., Ltd. is a Japan-based pharmaceutical company specializing in the research, development, and commercialization of innovative medicines. Formed in 2005 through the merger of Daiichi Pharmaceutical and Sankyo, the company focuses pri..
>Volltext.. |
| 26894.89 Mio. EUR |
| 26157.93 Mio. EUR |
| 11815.93 Mio. EUR |
| 1560.09 Mio. EUR |
| 1291.57 Mio. EUR |
| 0.7 EUR |
| 2659.98 Mio. EUR |
| 3390.08 Mio. EUR |
| 715.14 Mio. EUR |
| 0.83 |
| 5.58% |
| -24.93% |
| 0.44 EUR |
| 2.86% |
| 3.7% |
| 30.03.26 - 0.21295445€ 29.09.25 - 0.2222064€ >weitere anzeigen... |
| - |
| DAIICHI SANKYO |
| 17.08.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|